BioSpace News Archive

Drug Development

Nordic Nanovector to Present Preclinical Data Highlighting the Anti-tumor Effect of Humalutin® in Three Lymphoma Models at AACR 2018

Nordic Nanovector ASA announces that it will present a poster reporting the anti-tumour effect of Humalutin® (177Lu-conjugated humanized anti-CD37 antibody, 177Lu-NNV003) in preclinical models of non-Hodgkin’s lymphoma at the AACR Annual Meeting 2018.

March 15, 2018
·
1 min read
Drug Development

Transgene to Present Data on a Novel Viral Vector with Superior Anti-Cancer Immunotherapeutic Activity at AACR 2018

TRANSGENE will be presenting a poster with new and encouraging preclinical data on a novel viral vector (pseudocowpox, PCPV) at the AACR Annual Meeting 2018, Chicago, IL, USA, April 14 – 18.

March 15, 2018
·
1 min read
Genetown

Biogen to Present at the Advances in Alzheimer’s and Parkinson’s Therapies, an AAT-AD/PD Focus Meeting

Biogen Inc. announced that it will present at the Advances in Alzheimer’s and Parkinson’s Therapies, an AAT-AD/PD Focus Meeting.

March 15, 2018
·
1 min read
Business

Soligenix Announces Recent Accomplishments And Year-End 2017 Financial Results

Announced today its recent accomplishments and financial results for the year ended December 31, 2017.

March 15, 2018
·
8 min read
Biotech Bay

FDB Releases Opioid Risk Management Drug Knowledge to Reduce the Risk of Opioid-Related Overdose and Addiction Potential

Cloud-based drug knowledge enables safe opioid prescribing, dispensing and oversight.

March 15, 2018
·
6 min read
Business

Ionis and Akcea Partner to Commercialize Inotersen for hATTR

Collaboration advances commercial readiness for planned mid-2018 inotersen launch, positioning Akcea to successfully launch two drugs for significant rare diseases this year.

March 15, 2018
·
12 min read
Drug Development

Alexion Announces Positive Top-Line Results Showing Successful Phase 3 Clinical Study of ALXN1210 in Complement Inhibitor Treatment-Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

Regulatory Submissions Planned in the United States, European Union, and Japan in the Second Half of 2018

March 15, 2018
·
18 min read
Business

Center Point Clinical Services Names Gerald E. Finken New CEO

Center Point relocates headquarters to Fargo, ND, enhances its Siteless CRO model for the pharmaceutical industry and launches the specialty CTRP® program.

March 15, 2018
·
3 min read
Policy

Castle Biosciences Announces Receipt of New York Laboratory Permit

The receipt of the New York permit allows patients in that state to benefit from the Company’s DecisionDx®-Melanoma, DecisionDx®-UM and DecisionDx®-PRAME molecular diagnostic tests that provide actionable molecular information to inform patient care decisions.

March 15, 2018
·
2 min read
Business

Pandion Announces Formation of Scientific Advisory Board

The inaugural members include Diane Mathis, PhD, Scott Snapper, MD, PhD, Ananda Goldrath, PhD and David H. Sachs, MD.

March 15, 2018
·
3 min read